What To Know: FDA Approves Apomorphine for Parkinson Disease
Drug Topics
FEBRUARY 10, 2025
Expert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Mon.Feb 10, 2025
459 
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments
PharmaVoice
FEBRUARY 10, 2025
Fractyl Health is entering pivotal studies for a procedure that aims to be an ‘off ramp’ to GLP-1s and exploring how a one-time, ‘smart GLP-1’ gene therapy can Treat type 2 diabetes.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Adults with Chronic Pain Support Cannabis Use More Than Physicians
Drug Topics
FEBRUARY 10, 2025
Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.
Are orexins the next golden child of neuroscience?
PharmaVoice
FEBRUARY 10, 2025
An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Understanding Flublok® (Influenza Vaccine)
Drug Topics
FEBRUARY 10, 2025
Sponsored Content: This video is sponsored by Sanofi.
Investigators Use Sequencing Methods to Identify Triggering Allergen in Patient With EoE
Pharmacy Times
FEBRUARY 10, 2025
The authors are optimistic that this method can be replicated to identify other allergens that manifest into eosinophilic esophagitis (EoE).
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study Links PTSD to Higher Rates of Heart Disease in Vietnam Veterans
Pharmacy Times
FEBRUARY 10, 2025
Vietnam war trauma continues to affect veterans health 50 years later.
Reducing Opioid Prescriptions for Lower Back Pain Increases NSAID, Paracetamol Use
Drug Topics
FEBRUARY 10, 2025
Reducing the number of opioid prescriptions for patients with lower back pain did not result in an increased use of other, risky pain medications.
Artificial Intelligence and Drug Discovery—We Aren’t in Kansas Anymore, Toto
Pharmacy Times
FEBRUARY 10, 2025
The speed and scale of whats coming with AI can only be imagined now, but without a doubt, our lives will change.
FDA Grants Fast Track Designation to Rezpegaldesleukin for Atopic Dermatitis
Drug Topics
FEBRUARY 10, 2025
Data from a previous phase 1b trial show improvements in the Eczema Area and Severity Index (EASI)-75 compared with the placebo at 12 weeks.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 10, 2025
The nonprofit shared a $569 million operating income (0.3% operating margin) and $12.9 billion bottom line, the latter of which included $6.8 billion in one-time income from the Geisinger Health and Cone Health acquisitions.
FDA clears new antibiotic for superbug infections
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 10, 2025
The major nonprofit system declined to put a number on the cuts and consolidations, but pointed to a $250 million two-year budget gap it's seeking to address. Media reports place the anticipated headcount in the hundreds.
Share in cystic fibrosis firm Sionna rise sharply after IPO
pharmaphorum
FEBRUARY 10, 2025
Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 10, 2025
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good newsor the badfrom your shop, and we will feature it here at the end of each week.
Fourth person receives eGenesis’ gene-edited pig kidney transplant
Pharmaceutical Technology
FEBRUARY 10, 2025
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
FDA Accepts Biologics License Application for Pertuzumab Biosimilar to Treat Breast Cancer
Pharmacy Times
FEBRUARY 10, 2025
If approved, HLX11 could offer a more cost-effective alternative to pertuzumab for the treatment of human epidermal growth factor receptor 2-positive breast cancer.
Super Bowl ad for copycat weight loss drugs stokes pharma power debate
Pharmaceutical Technology
FEBRUARY 10, 2025
Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Novel Molecular Imaging Agent for Detection of Bowel Inflammation in Crohn Disease Receives FDA FTD
Pharmacy Times
FEBRUARY 10, 2025
BR55, an injection of perfluorobutane/nitrogen lipopeptide-coated microbubbles, could aid in the detection of angiogenesis and allow for earlier diagnosis in patients with Crohn disease.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 10, 2025
Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a spokesperson for Elevance confirmed to Fierce Healthcare.
Investigational Vvax001 Vaccine Shows Significant Potential in Reducing Precancerous Cervical Lesions
Pharmacy Times
FEBRUARY 10, 2025
The therapeutic vaccine could provide patients with a non-surgical alternative to traditional treatment approaches.
Pliant slumps on decision to pause lung disease drug trial
pharmaphorum
FEBRUARY 10, 2025
Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.
Expert: Patients on GLP-1s Should Consider Dietary Changes, Possible Side Effects During Treatment
Pharmacy Times
FEBRUARY 10, 2025
Proper nutrition and awareness of potential side effects from GLP-1 medications are essential for patients undergoing treatment.
Eton secures US patent for diabetes insipidus treatment
Pharmaceutical Technology
FEBRUARY 10, 2025
Eton has secured a patent from the USPTO for its ET-600 product candidates desmopressin oral solution formulation for diabetes insipidus.
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer
Pharmacy Times
FEBRUARY 10, 2025
The indication is for patients with endometrial cancer who may benefit from treatment with ACR-368 (Acrivon Therapeutics).
Boehringer seeks approval of lung disease drug after second Phase III success
Pharmaceutical Technology
FEBRUARY 10, 2025
Nerandomilast is posed to be Boehringer Ingelheims successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
Iclepertin Fails to Show Statistically Significant Effects on Cognition and Functioning in Patients With Schizophrenia
Pharmacy Times
FEBRUARY 10, 2025
In the phase 3 CONNEX clinical trial program, iclepertin did not meet its primary and secondary end points.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 10, 2025
Rhapsodys Chief Product Officer Jitin Asnaani discusses how to connect the dots between disparate patient records from multiple specialist departments to create a clear picture of patient needs.
Management of Tardive Dyskinesia and Comorbidities
Pharmacy Times
FEBRUARY 10, 2025
Panelists discuss how managing tardive dyskinesia in patients with comorbid mental health conditions requires a delicate balance between treating TD symptoms while maintaining psychiatric stability, emphasizing the importance of coordinated care between psychiatrists and movement disorder specialists to optimize medication regimens, monitor for potential drug interactions, and address the complex interplay between physical symptoms and psychological well-being.
Public health strategies skip patients with rare diseases, says UK study
Pharmaceutical Technology
FEBRUARY 10, 2025
A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the general population.
Shared Decision-Making in Tardive Dyskinesia
Pharmacy Times
FEBRUARY 10, 2025
Panelists discuss how TD treatment can be optimized through individualized approaches that consider patient-specific factors like symptom severity, comorbidities, concurrent medications, and daily routines, utilizing tools like titration kits to carefully adjust VMAT2 inhibitor dosing while monitoring response and tolerability to achieve the best possible outcomes for each patient.
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
Pharmaceutical Technology
FEBRUARY 10, 2025
China's NMPA has granted approval for Keymed Biosciences supplemental NDA of Stapokibart to treat seasonal allergic rhinitis.
Operational Challenges and Collaborative Strategies for Outpatient Cellular Therapy: Insights From Zahra Mahmoudjafari, PharmD, BCOP, FHOPA
Pharmacy Times
FEBRUARY 10, 2025
Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, discusses the logistical challenges and interprofessional strategies essential for delivering cellular therapies in outpatient settings, emphasizing the pharmacist's role in improving patient outcomes and addressing health disparities.
Let's personalize your content